Effect of naloxone-precipitated morphine withdrawal on c-fos expression in rat corticotropin-releasing hormone neurons in the paraventricular hypothalamus and extended amygdala


Autoria(s): Hamlin, A. S.; Buller, K. M.; Day, T. A.; Osborne, P. B.
Contribuinte(s)

S. G. Waxman

Data(s)

01/01/2004

Resumo

Morphine withdrawal is characterized by physical symptoms and a negative affective state. The 41 amino acid polypeptide corticotropin-releasing, hormone (CRH) is hypothesized to mediate, in part, both the negative affective state and the physical withdrawal syndrome. Here, by means of dual-immunohistochemical methodology, we examined the co-expression of the c-Fos protein and CRH following naloxone-precipitated morphine withdrawal. Rats were treated with slow-release morphine 50 mg/kg (subcutaneous, s.c.) or vehicle every 48 It for 5 days, then withdrawn with naloxone 5 mg/kg (s.c.) or saline 48 h after the final morphine injection. Two hours after withdrawal rats were perfused transcardially and their brains were removed and processed for immunohistochemistry. We found that naloxone-precipitated withdrawal of morphine-dependent rats increased c-Fos immunoreactivity (IR) in CRH positive neurons in the paraventricular hypothalamus. Withdrawal of morphine-dependent rats also increased c-Fos-IR in the central amygdala and bed nucleus of the stria terminalis. however these were in CRH negative neurons. (C) 2004 Published by Elsevier Ireland Ltd.

Identificador

http://espace.library.uq.edu.au/view/UQ:74680

Idioma(s)

eng

Publicador

Elsevier

Palavras-Chave #Neurosciences #Morphine Withdrawal #C-fos #Corticotropin-releasing Hormone #Paraventricular Hypothalamus #Amygdala #Immunohistochemistry #Opiate Withdrawal #Stria Terminalis #Central Nucleus #Bed Nucleus #Brain #Immunoreactivity #Identification #Consequences #Activation #Stress #C1 #320702 Central Nervous System #730104 Nervous system and disorders
Tipo

Journal Article